Back to results
US 11,448,650 B2Granted
Methods for diagnosing high-risk cancer using polysialic acid and one or more tissue-specific biomarkers
AssigneeGlyca Inc.
InventorsKarla Williams, Hon Sing Leong
Life of this patent
Estimating the term…
Abstract
Described herein are methods for diagnosing high-risk cancer in a subject by detecting PolySialic Acid (polySia) in a biological sample obtained from the subject, or by detecting polySia and one or more tissue-specific markers in a biological sample obtained from the subject.
Claims6
A method of diagnosing prostate cancer in a subject, the method comprising:
- providing a subject identified as having at least 2,000 prostate cancer extracellular vesicles that are triple-positive for polySia, STEAP1, and PSMA per microliter of biological sample;
- and
- performing a prostate needle-core biopsy on the subject.
Dependencies are inferred from the claim text.